Related Experiment Videos
Glomerular vascular cell adhesion molecule-1 expression in renal vasculitis
1Renal Research Laboratories, Queen Elizabeth Medical Centre, Edgbaston, Birmingham.
Journal of Clinical Pathology
|March 1, 1996
Summary
Vascular Cell Adhesion Molecule-1 (VCAM-1) is expressed in the glomeruli of patients with systemic vasculitis and Henoch-Schönlein purpura (HSP), correlating with more severe kidney damage. This suggests VCAM-1 may play a role in the glomerular injury seen in these conditions.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Systemic vasculitis and Henoch-Schönlein purpura (HSP) are inflammatory conditions affecting the kidneys.
- Understanding the molecular mechanisms of glomerular inflammation is crucial for effective treatment.
Purpose of the Study:
- To investigate the expression of cell adhesion molecules (ICAM-1, VCAM-1, E-selectin) in renal biopsies of patients with systemic vasculitis and HSP.
- To correlate the expression of these molecules with the severity of glomerular inflammation.
Main Methods:
- Renal biopsy specimens from patients with systemic vasculitis (Wegener's granulomatosis, microscopic polyarteritis), HSP, and controls were analyzed.
- Immunohistochemistry using monoclonal antibodies against ICAM-1, VCAM-1, and E-selectin was performed.
Main Results:
- Normal kidneys showed ICAM-1 and VCAM-1 expression in specific glomerular and interstitial cells.
- E-selectin was not detected in any biopsy specimens.
- VCAM-1 was expressed in glomerular endocapillary cells in a subset of patients with systemic vasculitis and HSP.
- Glomerular VCAM-1 expression correlated with a higher percentage of glomeruli involved in patients with systemic vasculitis.
Conclusions:
- VCAM-1 expression in glomerular endocapillary cells suggests a potential role in leukocyte recruitment.
- This recruitment may contribute to glomerular injury in conditions like Wegener's granulomatosis and microscopic polyarteritis.
- Further research into VCAM-1's role could inform therapeutic strategies for these kidney diseases.